New study aims to improve rectal cancer treatment by tracking patient outcomes
NCT ID NCT07501845
First seen Apr 08, 2026 · Last updated May 13, 2026 · Updated 4 times
Summary
This study is gathering information from about 999 people with rectal cancer who are treated with a special device called the MAASTRO HDR applicator. The goal is to learn how well this treatment works and what side effects it may cause, so doctors can improve future care. Participants will be followed for up to 10 years to track their health and recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maastro
RECRUITINGMaastricht, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.